As HDAC modulates the acetylation status of histone and other important nonhistone cellular proteins, they have been recognized as potential therapeutic targets for a broad range of human disorders [11] and inhibition of HDAC has been suggested as a new therapeutic intervention of potential importance in type 2 diabetes [12]. The gene discussed is HDAC9; the disease is type 2 diabetes mellitus.